Kazan Didem, Odyakmaz-Demirsoy Evren, Eloglu Hatice, Kiran Rebiay
From the Department of Dermatology, Kocaeli University, Kocaeli, Turkey.
Indian J Dermatol. 2023 May-Jun;68(3):354. doi: 10.4103/ijd.ijd_152_23.
Allergic contact dermatitis is common in childhood as well as in adulthood. Children could be affected by numerous allergens. Allergen sources could change by region. In this study, we aimed to identify the most common allergens that cause contact sensitivity in paediatric patients in our region to make a standardized patch test series and define the ways of exposure to these allergens.
Between June 2013 and January 2021, a total of 61 patients' European baseline series patch test results were evaluated.
Among 61 patients, 36 (%59) were female and 25 (%41) were male. The mean age was 10.4 years. Positivity with at least one allergen was present in 39 (64%) cases. The most common allergens with positive reactions were balsam of Peru (BOP) in 11 (18%) patients, nickel in eight (13.1%) patients, and fragrance mix-1 in seven (11.4%) patients. No statically significant difference was found between patch test results and gender ( = 0.109), atopy ( = 0.774), atopic dermatitis ( = 0.662), hobby ( = 0.377) and side of lesions ( = 0.826). However, there was a significant relationship between the duration of complaints and patch test results ( = 0.007).
The responsible allergen in paediatric patients may vary especially by region, thus this could be challenging for diagnosis. Therefore, each region should create its own specific standardized paediatric patch tests.
过敏性接触性皮炎在儿童期和成年期都很常见。儿童可能会受到多种过敏原的影响。过敏原来源可能因地区而异。在本研究中，我们旨在确定在我们地区导致儿科患者接触性敏感的最常见过敏原，以制作标准化的斑贴试验系列，并确定接触这些过敏原的途径。
在2013年6月至2021年1月期间，共评估了61例患者的欧洲基线系列斑贴试验结果。
61例患者中，36例（59%）为女性，25例（41%）为男性。平均年龄为10.4岁。39例（64%）患者对至少一种过敏原呈阳性反应。反应呈阳性的最常见过敏原是秘鲁香脂（BOP），有11例（18%）患者；镍，有8例（13.1%）患者；香料混合物-1，有7例（11.4%）患者。斑贴试验结果与性别（P = 0.109）、特应性（P = 0.774）、特应性皮炎（P = 0.662）、爱好（P = 0.377）和皮损部位（P = 0.826）之间未发现统计学上的显著差异。然而，主诉持续时间与斑贴试验结果之间存在显著关系（P = 0.007）。
儿科患者中引起过敏的过敏原可能因地区而异，因此这可能给诊断带来挑战。因此，每个地区都应制定自己特定的标准化儿科斑贴试验。
